Distinct roles of Mdm2 and Mdm4 in red cell production

被引:57
作者
Maetens, Marion
Doumont, Gilles
De Clercq, Sarah
Francoz, Sarah
Froment, Pascal
Bellefroid, Eric
Klingmuller, Ursula
Lozano, Guillermina
Marine, Jean-Christophe
机构
[1] Univ Ghent VIB, Flanders Inst Biotechnol, Lab Mol Canc Biol, B-9052 Ghent, Belgium
[2] Free Univ Brussels VIB, Mol Embryol Lab, Gosselies, Belgium
[3] German Canc Res Ctr, D-6900 Heidelberg, Germany
[4] Univ Texas, MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA
[5] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2006-03-013656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mdm2 and Mdm4 are critical negative regulators of the p53 tumor suppressor. Mdm4-null mutants are severely anemic and exhibit impaired proliferation of the fetal liver erythroid lineage cells. This phenotype may indicate a cell-intrinsic function of Mdm4 in erythropoiesis. In contrast, red blood cell count was nearly normal in mice engineered to express low levels of Mdm2, suggesting that Mdm2 might be dispensable for red cell production. Here, we further explore the tissue-specific functions of Mdm2 and Mdm4 in the erythroid lineage by intercrossing conditional Mdm4 and Mdm2 alleles to an erythroid-specific Cre (Er-GFP-Cre) knock-in allele. Our data show that Mdm2 is required for rescuing erythroid progenitors from p53-mediated apoptosis during primitive erythropoiesis. In contrast, Mdm4 is only required for the high erythropoietic rate during embryonic definitive erythropoiesis. Thus, in this particular cellular context, Mclm4 only contributes to p53 regulation at a specific phase of the differentiation program.
引用
收藏
页码:2630 / 2633
页数:4
相关论文
共 50 条
[31]   MDM2 and MDM4: p53 regulators as targets in anticancer therapy [J].
Toledo, Franck ;
Wahl, Geoffrey M. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8) :1476-1482
[32]   Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma [J].
Guo, Ying ;
Pajovic, Sanja ;
Gallie, Brenda L. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 375 (01) :1-5
[33]   MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma [J].
Forschner, Andrea ;
Hilke, Franz-Joachim ;
Bonzheim, Irina ;
Gschwind, Axel ;
Demidov, German ;
Amaral, Teresa ;
Ossowski, Stephan ;
Riess, Olaf ;
Schroeder, Christopher ;
Martus, Peter ;
Klumpp, Bernhard ;
Gonzalez-Menendez, Irene ;
Garbe, Claus ;
Niessner, Heike ;
Sinnberg, Tobias .
CANCERS, 2020, 12 (03)
[34]   Depletion of Mdm2 and Mdm4 by adenovirus: Molecular mechanism and anticancer therapeutic implication [J].
Liao, Daiqing ;
Zhao, Lisa Y. ;
Yang, Heng .
CANCER RESEARCH, 2011, 71
[35]   Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer [J].
Bartnykaite, Agne ;
Savukaityte, Aiste ;
Ugenskiene, Rasa ;
Dauksaite, Monika ;
Korobeinikova, Erika ;
Gudaitiene, Jurgita ;
Juozaityte, Elona .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) :1-11
[36]   Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review [J].
Teveroni, Emanuela ;
Luca, Rossella ;
Pellegrino, Marsha ;
Ciolli, Germana ;
Pontecorvi, Alfredo ;
Moretti, Fabiola .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (12) :1417-1429
[37]   Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection [J].
Yang, Heng ;
Zheng, Zhi ;
Zhao, Lisa Y. ;
Li, Qiang ;
Liao, Daiqing .
CELL CYCLE, 2012, 11 (03) :582-593
[38]   Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4 [J].
Grier, JD ;
Xiong, SB ;
Elizondo-Fraire, AC ;
Parant, JM ;
Lozano, G .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) :192-198
[39]   MDM2与MDM4抑制剂的研究进展 [J].
李春红 ;
杜宏金 ;
温小安 ;
孙宏斌 .
中国药科大学学报, 2015, 46 (01) :1-15
[40]   Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 [J].
Marine, J-C ;
Francoz, S. ;
Maetens, M. ;
Wahl, G. ;
Toledo, F. ;
Lozano, G. .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (06) :927-934